Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H27FN2O2 |
| Molecular Weight | 358.4497 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC=C1N2CCN(CCCC(O)C3=CC=C(F)C=C3)CC2
InChI
InChIKey=LCZRXFYSMJIDQQ-UHFFFAOYSA-N
InChI=1S/C21H27FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11,20,25H,4,6,12-16H2,1H3
| Molecular Formula | C21H27FN2O2 |
| Molecular Weight | 358.4497 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Anisopirol is a neuroleptic and was used as antipsychotic drug. Anisopirol, the alcohol resulting from reduction of the carbonyl group of fluanisone, is an exception and is in fact about two times more potent than fluanisone itself. Anisopirol is poorly absorbed by the oral route. Dopamine receptor is known pharmacological target of anisopirol and NMDA receptor is predicted target.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:28:57 GMT 2023
by
admin
on
Fri Dec 15 15:28:57 GMT 2023
|
| Record UNII |
162A01WTAJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
167758
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
857-62-5
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
C74174
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
100000086929
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL104515
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
DTXSID20861938
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
162A01WTAJ
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
13333
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
1603
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
SUB05521MIG
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
